ticagrelor,bentracimab
astrazeneca,phasebio pharmaceutical,i-mab
['ticagrelor', 'bentracimab', 'bentra', 'imab ']
 presenting on bentracimab - a monoclonal antibody that reliably reverses the antiplatelet effects of ticagrelor. reverse it trial show promise for patients on ticagrelor with major bleeding or needing to undergo and invasive procedure #esccongress 
We focus on education about issues related to #bloodclots (#thrombosis) and #cardiovascular diseases such as #DVT, #PE, #afib, #diabetes, and #stroke.